Pursuant to New York Stock Exchange Rule 303A.08, Employee Inducement Awards Are Granted by Teladoc

March 17, 2017

LEWISVILLE, Texas--(BUSINESS WIRE)-- Teladoc, Inc. (NYSE: TDOC) announced today that it has granted non-qualified stock options to new employees as material inducements to their hiring. Stock options for the purchase of a total of eighty-eight thousand shares of Teladoc’s common stock, par value $0.001 per share (“Common Stock”), at a price per share of $22.30 were made to a total of fifteen persons. In addition, in conjunction with his recent hiring as executive vice president and chief revenue officer, Mr. Peter N. Nieves received a non-qualified stock option to purchase four hundred thousand shares of Common Stock at a price per share of $21.15.

Each of the options awarded vests as to twenty-five percent of the shares it covers on the first anniversary of its grant, with the remainder of the shares vesting ratably over thirty-six months thereafter. All of the options were granted outside the terms of Teladoc’s 2015 Incentive Award Plan in reliance on the employment inducement exemption under the NYSE’s Listed Company Manual Rule 303A.08. Pursuant to the requirements of that rule, Teladoc is issuing this press release.

About Teladoc

Teladoc, Inc. (NYSE:TDOC) is the nation’s leading provider of telehealth services and a pioneering force in bringing the virtual care visit into the mainstream of today’s health care ecosystem. Serving some 7,500 clients — including health plans, health systems, employers and other organizations — more than 17.5 million members can use phone, mobile devices and secure online video to connect within minutes to Teladoc’s network of more than 3,100 board-certified, state-licensed physicians and behavioral health specialists, 24/7. With national coverage, a robust, scalable platform and a Lewisville, TX-based member services center staffed by 400 employees, Teladoc offers the industry’s most comprehensive and complete telehealth solution including primary care, behavioral health care, dermatology, tobacco cessation and more. For additional information, please visit www.teladoc.com.

Source: Teladoc, Inc.

For Teladoc, Inc.


Jisoo Suh, 914-265-6706

Director of Investor Relations